title: Soluble HLA levels in early pregnancy after in vitro fertilization.
abstract: Intact pregnancy can be interpreted as a state of maternal immunotolerance toward an haploidentical fetus. Soluble HLA (sHLA) molecules increase during episodes of allograft rejection and are discussed as candidates to modulate immune responses. We questioned whether after in vitro fertilization (IVF) the subsequent intact pregnancy, early abortion, or tubal pregnancy influence the courses sHLA serum levels. Therefore, serum samples of 65 IVF patients were assayed by ELISA for sHLA-I, sHLA-G, and sHLA-DR concentrations preovulatorily and after a positive HCG test weekly until the 9th gestational week (GW). In 20 patients experiencing an early abortion the preovulatory sHLA-G mean level of 25.9 +/- 3.9 SEM ng/ml and the share of 4.2 +/- 0.8 SEM % on total sHLA-I were significantly (p < 0.05) reduced compared to women with intact pregnancy. The same differences (p < 0.0001) were seen during the monitoring of sHLA-G and sHLA-I levels in intact pregnancy versus early abortion until 9th GW. Twin pregnancy revealed a drastically increase of sHLA-G levels from the 8th GW compared to singleton pregnancies. Further, individual sHLA-DR levels increased during intact pregnancy but decreased in the group of early abortion. With regard to sensitivity and specificity for pregnancy outcome sHLA quantitation reached similar weight as routine HCG determinations at GW 5. Especially women with preovulatory low sHLA-G levels appear to be on risk for early abortion after IVF.
authors.affiliation: Department of Gynecology and Obstetrics, University of Bonn, Bonn, Germany.
authors.forename: K A
authors.initials: KA
authors.lastname: Pfeiffer
authors.forename: V
authors.initials: V
authors.lastname: Rebmann
authors.forename: M
authors.initials: M
authors.lastname: Pässler
authors.forename: K
authors.initials: K
authors.lastname: van der Ven
authors.forename: H
authors.initials: H
authors.lastname: van der Ven
authors.forename: D
authors.initials: D
authors.lastname: Krebs
authors.forename: H
authors.initials: H
authors.lastname: Grosse-Wilde
mesh_terms: D000022:Abortion, Spontaneous; D005260:Female; D005307:Fertilization in Vitro; D006680:HLA Antigens / Q000097:blood*; D006684:HLA-DR Antigens / Q000097:blood; D015395:Histocompatibility Antigens Class I / Q000097:blood; D006801:Humans; D011247:Pregnancy / Q000276:immunology*; D011256:Pregnancy Outcome; D011264:Pregnancy Trimesters / Q000097:blood*; D011274:Pregnancy, Tubal; D001613:beta 2-Microglobulin / Q000097:blood
chemical_list: D006680:HLA Antigens; D006684:HLA-DR Antigens; D015395:Histocompatibility Antigens Class I; D001613:beta 2-Microglobulin